Katholieke Universiteit Leuven

News Katholieke Universiteit Leuven

• New angle to combat malignant brain tumors in children

  A medulloblastoma is a malignant brain tumor that occurs primarily in children and is currently untreatable. Peter Carmeliet and his team (VIB-KU Leuven) joined forces with scientists at Massachusetts General Hospital in Harvard to study the role of the placental growth factor (PIGF) in the growth o more

• Oncodesign and LNGT: research collaboration for advancing drug discovery efforts with Ipsen in Parkinson's disease

  Oncodesign and the Laboratory for Neurobiology and Gene Therapy (LNGT) at the department of neurosciences at the KU Leuven, an academic group exploring the roles of LRRK2 and a-synuclein in Parkinson’s disease headed by Professor Veerle Baekelandt, announced that they have entered into a research co more

• VIB scientists present method to reduce error rate in detecting genomic variants by short-read sequencing

  Despite advanced genome technologies, it remains a major challenge to identify small variations between the hereditary material (DNA) of different individuals. VIB scientists connected to the K.U.Leuven and the University of Antwerp describe in Nature Biotechnology a method that makes it possible to more

Publications Katholieke Universiteit Leuven

• Closure of population biobanks and direct-to-consumer genetic testing companies

  Abstract   Genetic research gained new momentum with the completion of the Human Genome Project in 2003. Formerly centered on the investigation of single-gene disorders, genetic research is increasingly targeting common complex diseases and in doing so is studying the whole genome, the environme more

• Children and biobanks: a review of the ethical and legal discussion

  Abstract   The use of tissue samples from children is vital to genetic research. Collections of such tissue, in so-called biobanks, can take the form of large-scale prospective cohort studies or disease-specific studies using tissue of children with that specific disease. Collections of samples more

• The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?

  The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure? Content Type Journal Article Pages 1-4 DOI 10.1007/s11095-010-0313-5 Authors Jean-Paul Pirnay, Laboratory for Molecular and Cellular Technology Burn Wound Centre, Queen Astrid Military Hospital, 1120 Brussels, Belgium Daniel De Vo more

Websites Katholieke Universiteit Leuven